Stay updated on Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page has updated its date references, removing older dates and adding new ones, while also removing a specific location reference.
    Difference
    0.2%
    Check dated 2025-05-03T09:08:26.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-26T03:11:59.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The webpage has been updated to include new study results and additional details about the clinical trial for non-small cell lung cancer, including new locations and identifiers, while removing outdated information and clarifying study objectives and timelines.
    Difference
    39%
    Check dated 2025-04-18T21:53:47.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-04T16:13:29.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-03-28T06:59:54.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.6%
    Check dated 2025-02-20T11:42:05.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.